ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Second Intraperitoneal (I.P.) Infusion Cycle of Catumaxomab in Patients With Malignant Ascites (SECIMAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01065246
Recruitment Status : Completed
First Posted : February 9, 2010
Last Update Posted : October 3, 2012
Sponsor:
Information provided by (Responsible Party):
Neovii Biotech